site stats

Biorad sec filings

WebApr 28, 2024 · Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the first quarter ended March 31, 2024. First-quarter 2024 net sales were $700.1 million, a decrease of 3.7 percent compared to $726.8 million reported for the first quarter of 2024. … WebApr 13, 2024 · Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) have been assigned an average recommendation of “Buy” from the six research firms that are …

Bio-Rad Laboratories, Inc. (BIO) Stock Price Today, Quote & News

Web2 days ago · SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange Act ... WebApr 10, 2024 · Sumitomo Mitsui DS Asset Management Company Ltd raised its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 1.7% in the fourth quarter, according to its most recent ... mary holland smith https://clearchoicecontracting.net

Sumitomo Mitsui DS Asset Management Company Ltd Has …

WebMar 20, 2024 · BIO Bio-Rad Laboratories, Inc.SEC Filings. BIO. Bio-Rad Laboratories, Inc. 7.89K followers. $466.70 -3.17 ( -0.67%) 3:27 PM 03/20/23. NYSE $USD Realtime. … WebApr 6, 2024 · Bio-Rad Laboratories, Inc. SEC Filing - Quarterly Report (10-Q) October 28, 2024 Bio-Rad Laboratories, Inc. (BIO) Q3 2024 Earnings Call Transcript Bio-Rad Labs … WebApr 13, 2024 · Vaughan Nelson Investment Management L.P. boosted its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Rating) by 202.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission.The firm owned 3,715 shares of the medical research company's stock after … mary hollingsworth author

SEC.gov Filings & Forms - EDGAR

Category:Bio-Rad Reports First-Quarter 2024 Financial Results

Tags:Biorad sec filings

Biorad sec filings

BIO-RAD LABORATORIES, INC.: Daskal Ilan (EVP, Chief Financial …

WebSEC Filings for Bio-Rad Laboratories (BIO) including Annual 10-K and Quarterly 10-Q Reports. SEC Filings for Bio-Rad Laboratories (BIO) including Annual 10-K and Quarterly 10-Q Reports. ... SEC Filings are formal documents required by the government that describe the financial health and operating activities for any company that has publicly ... WebAccess Bio-Rad's most recent SEC filings. Please note that Bio-Rad does not maintain or provide information to Q4 Inc. In addition, Bio-Rad makes no representations or …

Biorad sec filings

Did you know?

WebLife Science Research. Bio-Rad Products. Genomics; Antibodies; Flow Cytometry; Transfection; Electrophoresis and Blotting; Imaging Systems & Software ; Bio-Plex Multiplex Immunoassay System WebFind the latest SEC Filings data for Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) at Nasdaq.com.

WebFeb 11, 2024 · HERCULES, Calif.–February 10, 2024–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, … WebFeb 16, 2024 · Current report filing. 04/11/2024. SC 13D/A. Amended Statement of Beneficial Ownership. 04/11/2024. 4. Statement of Changes in Beneficial Ownership. …

WebApr 11, 2024 · Exchange Traded Concepts LLC’s holdings in Bio-Rad Laboratories were worth $1,596,000 as of its most recent SEC filing. Several other hedge funds have also recently added to or reduced their ... WebApr 11, 2024 · The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 27.40% of the company's stock. Bio-Rad …

WebAbout SEC Filings. Nasdaq provides company’s SEC filings, which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia ...

WebJul 27, 2024 · 10x's Tuesday SEC filing related to the global settlement says the company also agreed to pay Bio-Rad over $29 million in royalties and interest related to sales of GEM products from the date of ... mary hollander boemWebSEC Filing Details. Form 4. 04/11/2024. Statement of Changes in Beneficial Ownership. PDF Format Download (opens in new window) Word Format Download (opens in new … mary hollis clark conference centerWebLife Science Research. Bio-Rad Products. Genomics; Antibodies; Digital PCR; Flow Cytometry; Transfection; Electrophoresis and Blotting ; Imaging Systems & Software mary-hollis hundleyWebMar 29, 2024 · SEC Filings. Select Year: Filter filing type: Date Filing Type Filing Description Download / View. 02/23/2024. 8-K. Current report filing. 02/17/2024. 10-K. … Bio-Rad is a global leader in developing, manufacturing, and marketing a broad … mary hollis inbodenWebApr 10, 2024 · Bio-Rad Laboratories Price Performance. Bio-Rad Laboratories stock opened at $466.24 on Monday. Bio-Rad Laboratories, Inc. has a 1 year low of $344.63 and a 1 year high of $607.54. mary hollis inboden ageWebApr 10, 2024 · The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 27.40% of the stock is owned by company insiders. Bio-Rad Laboratories Price Performance hurricane ian thoughts and prayersWebApr 13, 2024 · Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) have been assigned an average recommendation of “Buy” from the six research firms that are currently covering the firm, Marketbeat.com reports.Five investment analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that have … mary hollis huddleston